Confidence limits for the incidence of metabolic disorders screened in Switzerland.
The incidence of rare disorders in the population is usually indicated in the literature by a rate, without any confidence limits added. Using data of the Swiss screening program for metabolic disorders in newborns (provided by R.Gitzelmann and R.BBtler) we found that the occurence of elevated phenylalanine is compatible with a POISSON distribution (Chi square test, Kolmogorov-Smirnov test). Thus confidence limits can be established. Comparisons between different populations are easily tested statistically. The 95% confidence limits for the incidence of metabolic disorders screened in Switzerland are as follows:
per 100'000 1 in - The incidence of hypothyroidism found in Switzerland by TSH-assay is significantly higher (p<0.025) than that found in Quebec (16.6-25.3/100'000)by T4 screening.
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Gestational length and erythrocyte acid phosohatase (ACP1) phenotype. PASCONE R.*. LUCARELLI P.*, MATTEUCCI P*., LUCARINI Nt, GLORIA-BOTTINI Ff, CARA-PELLA E?, WALIISInM. and BOTTINI E. Dept. of Child Health, Univ. of Rome and'Dept. of Child Health. Univ. of Sassari. Italy.
We have previously reported a significant association between ACPl phenotype and serum bilirubin levels during the neonatal period (Lancet 1:918, 1976) . ACP acts in vivo as a flavin-mononucleotide phosphatase and may pisy a significant role during foetal development. A prospective study of 489 infants consecutively born in Rome was performed. Mean values for gestational age were similar among different ACP phenotypes, but variance ratios were highly significant (p c 0.013. The proportion of preterm infants (437 weeks gestation) was lowest (3.6%) among phenotypes heterozygous for P allele (BA and CB, . intermediate (6.7%) among homozygous B phenotypes (NO-238) and highest (13.6%) among phenotypes without pb . These data indicate that ACPlmay affect the length of gestation and that heterozygosity for pb allele of ACPl may represent an advantage in neonatal selection, They also provide the first clear example of the postulated selective advantage of heterozygotes for the main allele (pb) of a "normal" polymorphism (ACP1). (Work supported by grants from CNR and MF'I).
Study of nine genetic polymorphisms in asthmatic children. RONCHETTI R.*, TRAMUTOLI G . * , MACRI F.*, DISCEPOLI L.*. CARAPELLA E.*, EOTTINI E. Depts. of Pediatrics and Child Health. University of Rome-Itslv.
In order to better understand the genetic background of childhood asthma we determined in a group of asthmatic children living in Roo?.-the nhenorype for 9 polymorphic systems: ADA, PGM1, AK, Hp, ABO, Rh, MNSs (77 children), HLA A and B (36 children). Significant differencies between asthmatics and normal population were found for ADA (lower frequency of ADA 2-1, p (0.02). Secretor (lower frequency of Secretors p ( 0 . 0 1 ) , HLA (higher frequencv of pCO.O1), Rh (lower frequency of cc in males, p (0.05). Further investigation was carried out for ADA in another group of asthmatic children mostly from the northern part of Italy which confirmed the negative association between ADA 2-1 and asthma (total children 157, p ( 0 . 0 1 ) .
The analysis of clinical characteristics of patients showed that the age of onset of asthma was significantly lower for ADA 2-1. Eloreover there was a tendency for the same group to have heavier familiarity for atopy and lower frequency of positive prick-test. Supported by CNR, grant n079.01103. 83. It is well known that individuals homosygous for a rare sileni allele of A M may experienoe a severe oombined immunodefioienoj. By analogy we have investigated the possible relations of nonnal A M polymorphism with some oonditiona (such as asthma and fetomaternal re1ationsbip)tn whioh immunologioal meohanisms may play an important role.179 ohildren with bronohial aethms,46 oou-9108 with unexplained habitual abortion (AB),24 couples with un_ explained sterility (ST) ,229 oonseoutive newborns (CN) and 93 oonaeoutive low-birth-weight infanta (LBU) were studied.The pro_ portion of AM2-1 phenotype war drastioally reduced in asthmatic ahildren (p<0.01) and in AB and ST oouplea (p<0.02) .AM2-1 phenotype was assooiated with a significant reduotion (~~0.01) in the v~riahility of gestational length in CB;furthermore,the prs portion of A W -1 was signifioantly lower in LBY than in CN and norms1 adults (p<0.05).~he present data indioate for the firat time that genetio variability due to the "nomal" A M polymorp!! ism may be,at least in part,responaible for the variable hehavioor of immunologioal funotiona and related pethologioal oondi- Increasing attention is being focussed on perinatai health in the United Kingdom but little information relating to ethnic differences is available. This is especially important since clinical experience indicates that differences do exist.
The Perinatal mortality (PNM) of births to mothers living in the inner London Boroughs of Lambeth,Southwark and Wandsworth delivering at St.Thomasa Hospital from 1969 to 1976 has been examined. fhe PNM rate In the West lndian population is significantly higher than the UK white rate P<O.OOi. This increased West lndian PNM is confined to babies of 37 weeks gestational age and above and 2.0kgm birth weight and more. The relative risk of perinatai death in the West lndian compared with UK white mothers is 1.4 at 2.5 to 2.9kgm rising ts 3.0 at birth weights exceeding 4.0kgm. This excess is only partially explicable by social class differences. The increased relative risk is seen in West Indian women over 25 years of age and in ail parity groupings. West lndian women with pre-eclampsia or who are delivered with the aid af forceps are at greatly increased risk.
These findings suggest the existence of a generation effect and Indicate that there is an urgent need for further study.
